Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

Accumulating evidence demonstrates the decisive role of the gut microbiota in determining the effectiveness of anticancer therapeutics such as immunogenic chemotherapy or immune checkpoint blockade in preclinical tumor models, as well as in cancer patients. In synthesis, it appears that a normal int...

Descripción completa

Detalles Bibliográficos
Autores principales: Daillère, Romain, Derosa, Lisa, Bonvalet, Mélodie, Segata, Nicola, Routy, Bertrand, Gariboldi, Manuela, Budinská, Eva, De Vries, I. Jolanda M., Naccarati, Alessio Gordon, Zitvogel, Valérie, Caldas, Carlos, Engstrand, Lars, Loilbl, Sibylle, Fieschi, Jacques, Heinzerling, Lucie, Kroemer, Guido, Zitvogel, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466862/
https://www.ncbi.nlm.nih.gov/pubmed/32934879
http://dx.doi.org/10.1080/2162402X.2020.1774298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466862/
https://www.ncbi.nlm.nih.gov/pubmed/32934879
http://dx.doi.org/10.1080/2162402X.2020.1774298

Ejemplares similares